These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22776193)

  • 1. Validation studies on blood collection from the jugular vein of conscious mice.
    Shirasaki Y; Ito Y; Kikuchi M; Imamura Y; Hayashi T
    J Am Assoc Lab Anim Sci; 2012 May; 51(3):345-51. PubMed ID: 22776193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of hematologic and biochemical results on blood obtained by jugular venipuncture as compared with intravenous catheter in adult horses.
    May ML; Nolen-Walston RD; Utter ME; Boston RC
    J Vet Intern Med; 2010; 24(6):1462-6. PubMed ID: 20738771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
    Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Phlebotomy by Tail Tip Amputation, Facial Vein Puncture, and Tail Vein Incision in C57BL/6 Mice by Using Physiologic and Behavioral Metrics of Pain and Distress.
    Moore ES; Cleland TA; Williams WO; Peterson CM; Singh B; Southard TL; Pasch B; Labitt RN; Daugherity EK
    J Am Assoc Lab Anim Sci; 2017 May; 56(3):307-317. PubMed ID: 28535866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of blood samples from the saphenous vein compared with the tail vein during multiple blood sampling of mice.
    Aasland KE; Skjerve E; Smith AJ
    Lab Anim; 2010 Jan; 44(1):25-9. PubMed ID: 19535392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats.
    Gilor C; Graves TK; Gilor S; Ridge TK; Rick M
    Domest Anim Endocrinol; 2011 Jul; 41(1):42-9. PubMed ID: 21645806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
    Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
    Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of saphenous venipuncture and modified tail-clip blood collection in mice.
    Abatan OI; Welch KB; Nemzek JA
    J Am Assoc Lab Anim Sci; 2008 May; 47(3):8-15. PubMed ID: 18459706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia.
    Ionut V; Castro AV; Woolcott OO; Stefanovski D; Iyer MS; Broussard JL; Burch M; Elazary R; Kolka CM; Mkrtchyan H; Bediako IA; Bergman RN
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E644-52. PubMed ID: 25117408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating study.
    Gu N; Cho SH; Kim J; Shin D; Seol E; Lee H; Lim KS; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2014 Jan; 36(1):101-14. PubMed ID: 24373998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations.
    Greig NH; Holloway HW; De Ore KA; Jani D; Wang Y; Zhou J; Garant MJ; Egan JM
    Diabetologia; 1999 Jan; 42(1):45-50. PubMed ID: 10027577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.
    van Raalte DH; van Genugten RE; Linssen MM; Ouwens DM; Diamant M
    Diabetes Care; 2011 Feb; 34(2):412-7. PubMed ID: 21216851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological and pathological impact of blood sampling by retro-bulbar sinus puncture and facial vein phlebotomy in laboratory mice.
    Teilmann AC; Nygaard Madsen A; Holst B; Hau J; Rozell B; Abelson KS
    PLoS One; 2014; 9(11):e113225. PubMed ID: 25426941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide.
    Patterson S; de Kort M; Irwin N; Moffett RC; Dokter WH; Bos ES; Miltenburg AM; Flatt PR
    Diabetes Obes Metab; 2015 Aug; 17(8):760-70. PubMed ID: 25929155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel glucagon-like peptide-1 analog delivered orally reduces postprandial glucose excursions in porcine and canine models.
    Eldor R; Kidron M; Greenberg-Shushlav Y; Arbit E
    J Diabetes Sci Technol; 2010 Nov; 4(6):1516-23. PubMed ID: 21129350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents.
    Arakawa M; Ebato C; Mita T; Hirose T; Kawamori R; Fujitani Y; Watada H
    Biochem Biophys Res Commun; 2009 Dec; 390(3):809-14. PubMed ID: 19836346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agreement among three different equine venipuncture sites with regard to measurement of packed cell volume and total solids.
    Dahan R; Sutton GA; Oreff GL; Kelmer G
    Aust Vet J; 2015 Apr; 93(4):109-11. PubMed ID: 25817976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of E2HSA, a Long-Acting Glucagon Like Peptide-1 Receptor Agonist, on Glycemic Control and Beta Cell Function in Spontaneous Diabetic db/db Mice.
    Hou S; Li C; Huan Y; Liu S; Liu Q; Sun S; Jiang Q; Jia C; Shen Z
    J Diabetes Res; 2015; 2015():817839. PubMed ID: 26351642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
    Ahn S; Lee IH; Lee E; Kim H; Kim YC; Jon S
    J Control Release; 2013 Sep; 170(2):226-32. PubMed ID: 23747732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.